{"preliminary_commentary":{"by_channel":{"x_thread":19,"youtube":3,"podcast":2,"bluesky_thread":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02945566\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"name":"STAR-TREC","nct_id":"NCT02945566","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=star-trec-nct02945566. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1950,"size":"deep","size_rule":"Deep: 301+ verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"STAR-TREC","arms":[{"description":"Radical total mesorectal excision","label":"Standard TME surgery","type":"ACTIVE_COMPARATOR"},{"description":"Capecitabine: 825 mg/m² orally, b.i.d., on radiotherapy days Radiotherapy: A dose of 50 Gy, applied to the primary tumour and surrounding mesorectum, in 25 fractions of 2 Gy, 5 days a week.","label":"Long course concurrent chemoradiation","type":"EXPERIMENTAL"},{"description":"A dose of 25Gy, applied, to the primary tumour and surrounding mesorectum in 5 fractions of 5 Gy, 5 days a week.","label":"Short course radiotherapy","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2028-08","type":"ESTIMATED"},"conditions":["Adenocarcinoma of the Rectum"],"enrollment":{"count":380,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Standard TME surgery","otherNames":[],"type":"PROCEDURE"},{"name":"Long course concurrent chemoradiation with capecitabine and radiotherapy","otherNames":["Xeloda is the brand name for capecitabine"],"type":"DRUG"},{"name":"Short course radiotherapy","otherNames":[],"type":"RADIATION"}],"last_update":"2026-06-29","lead_sponsor":"University of Birmingham","official_title":"STAR-TREC: Can we Save the Rectum by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE2","PHASE3"],"primary_completion_date":{"date":"2027-08","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Phase II (Feasibility study) Primary Outcome: Recruitment Rate","timeFrame":"24 Months"},{"measure":"Phase III Primary Outcome: Organ Preservation","timeFrame":"30 Months from start day of (chemo)radiotherapy treatment."}],"references":[{"citation":"Motamedi MAK, Mak NT, Brown CJ, Raval MJ, Karimuddin AA, Giustini D, Phang PT. Local versus radical surgery for early rectal cancer with or without neoadjuvant or adjuvant therapy. Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD002198. doi: 10.1002/14651858.CD002198.pub3.","pmid":"37310167","type":"DERIVED"},{"citation":"Appelt AL, Kerkhof EM, Nyvang L, Harderwijk EC, Abbott NL, Teo M, Peters FP, Kronborg CJS, Spindler KG, Sebag-Montefiore D, Marijnen CAM; STAR-TREC collaborative group. Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer - A multicentre dose planning study. Tech Innov Patient Support Radiat Oncol. 2019 Oct 15;11:14-21. doi: 10.1016/j.tipsro.2019.09.001. eCollection 2019 Sep.","pmid":"32095545","type":"DERIVED"},{"citation":"van den Ende RPJ, Peters FP, Harderwijk E, Rutten H, Bouwmans L, Berbee M, Canters RAM, Stoian G, Compagner K, Rozema T, de Smet M, Intven MPW, Tijssen RHN, Theuws J, van Haaren P, van Triest B, Eekhout D, Marijnen CAM, van der Heide UA, Kerkhof EM. Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results. Radiat Oncol. 2020 Feb 18;15(1):41. doi: 10.1186/s13014-020-01487-6.","pmid":"32070386","type":"DERIVED"},{"citation":"Rombouts AJM, Al-Najami I, Abbott NL, Appelt A, Baatrup G, Bach S, Bhangu A, Garm Spindler KL, Gray R, Handley K, Kaur M, Kerkhof E, Kronborg CJ, Magill L, Marijnen CAM, Nagtegaal ID, Nyvang L, Peters FP, Pfeiffer P, Punt C, Quirke P, Sebag-Montefiore D, Teo M, West N, de Wilt JHW; for STAR-TREC Collaborative Group. Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ Open. 2017 Dec 28;7(12):e019474. doi: 10.1136/bmjopen-2017-019474.","pmid":"29288190","type":"DERIVED"}],"start_date":{"date":"2017-06-14","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Can we Save the Rectum by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?","url":"https://clinicaltrials.gov/study/NCT02945566"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/star-trec-nct02945566"}